Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hebei Xinanran Biotechnology Co., Ltd. is a Chinese biotech company focused on veterinary medicine, integrating R&D, production, and sales of veterinary drugs, feed additives, and animal health products. It operates over 10 production lines, including large-volume injections, powders, tablets, granules, and disinfectants. The company’s facilities are GMP-certified and designed to international (EU) standards. Its products are exported to Africa, the EU, and Southeast Asia, with annual trade income of nearly $10 million USD. No information is available on specific clinical results in humans.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Xinan Medicine.